Brief: Milestone Pharmaceuticals Inc - May Offer Securities Up To $300 Million - SEC Filing
13/05/2026 22:33
May 13 (Reuters) - Milestone Pharmaceuticals Inc MIST.O: MILESTONE PHARMACEUTICALS INC - MAY OFFER SECURITIES UP TO $300 MILLION - SEC FILING MILESTONE PHARMACEUTICALS INC - MAY OFFER UP TO $100 MILLION COMMON SHARES VIA CANTOR FITZGERALD SALES AGREEMENT - SEC FILING Source text: [ID:n0001104659-26-060391] Further company coverage: MIST.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Milestone Pharmaceuticals
See all newsBrief: Milestone Pharmaceuticals Announces First European Study Participant Enrolled In Revera-301 Phase 3 Clinical Trial
Brief: Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment To The Co
Milestone Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Canada's Milestone Pharma misses Q2 product revenue expectations
Milestone Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview